Skip to main content
Contact Us
Subscribe
E-Edition
73°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
Next >
Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program
August 21, 2024
Tags
Health & Science
Pharmaceuticals
Costco Wholesale Corp
From
CNBC.com News
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
August 20, 2024
Tags
Business
Health care industry
Breaking news
From
CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
August 15, 2024
Tags
Business News
Biotech and Pharmaceuticals
Biotechnology
From
CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
August 15, 2024
Tags
Politics
Amgen Inc
Bristol/Myers Squibb Co
From
CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
August 14, 2024
Tags
Biotech and Pharmaceuticals
Health & Science
Eli Lilly and Co
From
CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
August 13, 2024
Tags
Breaking News: Business
Business News
Biotechnology
From
CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
August 02, 2024
Tags
Companies
Breaking news
Business
From
CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
August 01, 2024
Tags
Health care industry
Business
Companies
From
CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
July 31, 2024
Tags
Science
Novo Nordisk A/S
Altimmune Inc
From
CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
July 30, 2024
Tags
US: News
Eli Lilly and Co
Novo Nordisk A/S
From
CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
July 29, 2024
Tags
Roche Holding AG
Business
Pharmaceuticals
From
CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
July 25, 2024
Tags
Business News
Breaking News: Business
Biotech and Pharmaceuticals
From
CNBC.com News
Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
July 25, 2024
Tags
Pharmaceuticals
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
July 23, 2024
Tags
Biotech and Pharmaceuticals
Merck & Co Inc
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment
July 23, 2024
Tags
Pharmaceuticals
Health & Science
Health care industry
From
CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
July 17, 2024
Tags
Business News
Novo Nordisk A/S
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
July 16, 2024
Tags
Health & Science
Health care industry
Healthy Returns
From
CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
July 11, 2024
Tags
Eli Lilly and Co
Health & Science
Novo Nordisk A/S
From
CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
July 11, 2024
Tags
Health & Science
Pharmaceuticals
Pfizer Inc
From
CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
July 10, 2024
Tags
Stock markets
Mad Money
Investing
From
CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
July 10, 2024
Tags
Sanofi SA
Business News
Biotechnology
From
CNBC.com News
CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
July 08, 2024
Tickers
LAWS
Tags
Breaking News: Politics
Streaming services
Corporate crime
From
CNBC.com News
CNBC Daily Open: French far-right advance blocked
July 07, 2024
Tags
NVIDIA Corp
Bitcoin
Technology
From
CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
July 06, 2024
Tags
Weight management
U/S/ Markets
Stock markets
From
CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
July 04, 2024
Tags
Biotechnology
Biotech and Pharmaceuticals
Deutsche Bank AG
From
CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
Tags
Cigna Corp
Technology
Healthy Returns
From
CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
Tags
Gilead Sciences Inc
Viking Therapeutics Inc
Health & Science
From
CNBC.com News
5 things to know before the stock market opens
June 25, 2024
Tags
Business News
Paramount Global
Economy
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
June 25, 2024
Tags
Europe: Top News And Analysis
Biotechnology
Biotech and Pharmaceuticals
From
CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
June 24, 2024
Tags
US: News
Eli Lilly and Co
Novo Nordisk A/S
From
CNBC.com News
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.